Samsung has unveiled the Galaxy Book 3, the Samsung All-in-One, and the Samsung Desktop this month, featuring the latest Intel 13th Gen Core processors.
The Galaxy Book 3, which boasts a slim metal design similar to the Galaxy Book 3 Pro, measures only 15.4mm thick and weighs a mere 1.57kg.
The Samsung All-in-One, the first one launched in two years, is slimmer compared to its predecessor, featuring reduced width, thickness, and stand width. It also has a removable “upgrade door” at the back, making it convenient and easy for users to replace memory.
Meanwhile, the Samsung Desktop comes in the Tower and Slim variants, both offering a sleek and uncluttered look. The tower model has a ‘popping door’ on the side, allowing users to open the body with one hand, making it easier to upgrade memory, SSDs, and graphics cards or clean the interior.
According to Samsung, the three new products significantly enhance the connectivity of their various Galaxy mobile products.


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Instagram Outage Disrupts Thousands of U.S. Users 



